These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 24229455)
21. Applications of high-throughput ADME in drug discovery. Kassel DB Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334 [TBL] [Abstract][Full Text] [Related]
22. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
23. Pharmacophore modeling and in silico toxicity assessment of potential anticancer agents from African medicinal plants. Ntie-Kang F; Simoben CV; Karaman B; Ngwa VF; Judson PN; Sippl W; Mbaze LM Drug Des Devel Ther; 2016; 10():2137-54. PubMed ID: 27445461 [TBL] [Abstract][Full Text] [Related]
26. Computational approaches towards the rational design of drug-like compound libraries. Matter H; Baringhaus KH; Naumann T; Klabunde T; Pirard B Comb Chem High Throughput Screen; 2001 Sep; 4(6):453-75. PubMed ID: 11562252 [TBL] [Abstract][Full Text] [Related]
27. Prioritization of anti-malarial hits from nature: chemo-informatic profiling of natural products with in vitro antiplasmodial activities and currently registered anti-malarial drugs. Egieyeh SA; Syce J; Malan SF; Christoffels A Malar J; 2016 Jan; 15():50. PubMed ID: 26823078 [TBL] [Abstract][Full Text] [Related]
28. IMPPAT: A curated database of Indian Medicinal Plants, Phytochemistry And Therapeutics. Mohanraj K; Karthikeyan BS; Vivek-Ananth RP; Chand RPB; Aparna SR; Mangalapandi P; Samal A Sci Rep; 2018 Mar; 8(1):4329. PubMed ID: 29531263 [TBL] [Abstract][Full Text] [Related]
29. Development of an ADME and drug-drug interactions knowledge database for the acceleration of drug discovery and development. Petitet F; Barberan O; Dubus E; Ijjaali I; Donlan M; Ollivier S; Michel A Expert Opin Drug Discov; 2006 Dec; 1(7):737-51. PubMed ID: 23495997 [TBL] [Abstract][Full Text] [Related]
30. truPK -- human pharmacokinetic models for quantitative ADME prediction. Subramanian K Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):555-64. PubMed ID: 16863461 [TBL] [Abstract][Full Text] [Related]
31. Structure-Based Study of Natural Products with Anti-Schistosoma Activity. Akachukwu I; Olubiyi OO; Kosisochukwu A; John MC; Justina NN Curr Comput Aided Drug Des; 2017; 13(2):91-100. PubMed ID: 28103771 [TBL] [Abstract][Full Text] [Related]
32. PK/DB: database for pharmacokinetic properties and predictive in silico ADME models. Moda TL; Torres LG; Carrara AE; Andricopulo AD Bioinformatics; 2008 Oct; 24(19):2270-1. PubMed ID: 18684738 [TBL] [Abstract][Full Text] [Related]
33. In Silico Absorption, Distribution, Metabolism, Excretion, and Pharmacokinetics (ADME-PK): Utility and Best Practices. An Industry Perspective from the International Consortium for Innovation through Quality in Pharmaceutical Development. Lombardo F; Desai PV; Arimoto R; Desino KE; Fischer H; Keefer CE; Petersson C; Winiwarter S; Broccatelli F J Med Chem; 2017 Nov; 60(22):9097-9113. PubMed ID: 28609624 [TBL] [Abstract][Full Text] [Related]
34. Three promising antimycobacterial medicinal plants reviewed as potential sources of drug hit candidates against multidrug-resistant tuberculosis. Tuyiringire N; Deyno S; Weisheit A; Tolo CU; Tusubira D; Munyampundu JP; Ogwang PE; Muvunyi CM; Heyden YV Tuberculosis (Edinb); 2020 Sep; 124():101987. PubMed ID: 32841928 [TBL] [Abstract][Full Text] [Related]
35. In Silico Screening of Antibacterial Compounds from Herbal Sources Against Vibrio cholerae. Perveen S; Chaudhary HS Pharmacogn Mag; 2015 Oct; 11(Suppl 4):S550-5. PubMed ID: 27013793 [TBL] [Abstract][Full Text] [Related]
36. A Chemometric Analysis of Deep-Sea Natural Products. Pilkington LI Molecules; 2019 Oct; 24(21):. PubMed ID: 31683674 [TBL] [Abstract][Full Text] [Related]
37. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach. Ambure P; Bhat J; Puzyn T; Roy K J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387 [TBL] [Abstract][Full Text] [Related]
38. ADME of biologics-what have we learned from small molecules? Prueksaritanont T; Tang C AAPS J; 2012 Sep; 14(3):410-9. PubMed ID: 22484625 [TBL] [Abstract][Full Text] [Related]
39. Improving early drug discovery through ADME modelling: an overview. Wishart DS Drugs R D; 2007; 8(6):349-62. PubMed ID: 17963426 [TBL] [Abstract][Full Text] [Related]
40. Strategy of utilizing in vitro and in vivo ADME tools for lead optimization and drug candidate selection. Balani SK; Miwa GT; Gan LS; Wu JT; Lee FW Curr Top Med Chem; 2005; 5(11):1033-8. PubMed ID: 16181128 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]